HNGE R&D Expense Growth
Hinge Health, Inc. Class A Common Stock · R&D Expense Growth
HNGE R&D Expense Growth
Latest reported265.07%period ending
HNGE FY R&D Growth (YoY) (0.00% → 265.07%)
Latest values, visible window
High-resolution chart · PNG
HNGE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 265.074% | |
| -8.3765% | |
| 0% |